Merck, 106333, CellPrime®r LR3 IGF powder

General description
CellPrime® rLR3 IGF is a is a non-animal origin (NAO) recombinant equivalent Insulin-like growth factor expressed in E.coli. CellPrime® rLR3 IGF has a 13 amino acid N-terminal extension and position 3 substitution of Glutamic acid to Arginine contributes to increased stability and robustness in media formulations.
Application
CellPrime® rLR3 IGF is used to optimize cell culture formulations to increase cell proliferation, productivity, and viability. With an exact match for the Type I IGF receptor and a lower affinity for IGF binding proteins, CellPrime® rLR3 IGF has increased effectiveness in serum-free cell culture media. Concentrations required to enhance performance is unique to each cell line and may be optimized by using in combination with CellPrime® rInsulin.
Packaging
106333.0005 / 5 MG /
106333.0050/ 50 MG /
106333.0250/ 250 MG /
106333.0500 / 500 MG /
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
CellPrime is a registered trademark of Merck KGaA, Darmstadt, Germany